Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5VT1

Crystal Structure of the Human CAMKK2B bound to a thiadiazinone benzamide inhibitor

5VT1 の概要
エントリーDOI10.2210/pdb5vt1/pdb
分子名称Calcium/calmodulin-dependent protein kinase kinase 2, 4-({5-[(3-hydroxy-4-methylphenyl)amino]-4-oxo-4H-1,2,6-thiadiazin-3-yl}amino)benzamide, MAGNESIUM ION, ... (4 entities in total)
機能のキーワードtransferase, protein kinase domain, structural genomics, structural genomics consortium, sgc, transferase-transferase inhibitor complex, transferase/transferase inhibitor
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数1
化学式量合計33520.95
構造登録者
主引用文献Asquith, C.R.M.,Godoi, P.H.,Counago, R.M.,Laitinen, T.,Scott, J.W.,Langendorf, C.G.,Oakhill, J.S.,Drewry, D.H.,Zuercher, W.J.,Koutentis, P.A.,Willson, T.M.,Kalogirou, A.S.
1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors.
Molecules, 23:-, 2018
Cited by
PubMed Abstract: We demonstrate for the first time that 4-1,2,6-thiadiazin-4-one (TDZ) can function as a chemotype for the design of ATP-competitive kinase inhibitors. Using insights from a co-crystal structure of a 3,5-bis(arylamino)-4-1,2,6-thiadiazin-4-one bound to calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2), several analogues were identified with micromolar activity through targeted displacement of bound water molecules in the active site. Since the TDZ analogues showed reduced promiscuity compared to their 2,4-dianilinopyrimidine counter parts, they represent starting points for development of highly selective kinase inhibitors.
PubMed: 29783765
DOI: 10.3390/molecules23051221
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.9 Å)
構造検証レポート
Validation report summary of 5vt1
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon